Fortress Biotech
FBIO
41 hedge funds and large institutions have $28.5M invested in Fortress Biotech in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 14 closing their positions.
315% more call options, than puts
Call options by funds: $282K | Put options by funds: $68K
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
15% less capital invested
Capital invested by funds: $33.7M → $28.5M (-$5.16M)
16% less funds holding
Funds holding: 49 → 41 (-8)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
+$1.22M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$1.13M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$431K |
| 4 |
BCM
Bluefin Capital Management
New York
|
+$260K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$1.67M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$850K |
| 3 |
SIM
Spark Investment Management
New York
|
-$415K |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$347K |
| 5 |
RA
Royce & Associates
New York
|
-$298K |
FBIO Hedge Fund Activity: Q2 2015 in Review
41 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2015, worth a combined $28.5M — down 15% from $33.7M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of FBIO and 6 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 14 added.
The largest buyer was Belmont Global Advisors, adding an estimated $1.22M. The largest seller was RTW Investments, cutting an estimated $1.67M.
- 41 institutional investors held Fortress Biotech (FBIO) as of Q2 2015, down from 49 in Q1 2015.
- Funds reported $28.5M of Fortress Biotech stock for Q2 2015, down 15% quarter-over-quarter.
- 6 funds opened new Fortress Biotech positions in Q2 2015 and 14 closed out, a net change of -8 holders.
- The largest Fortress Biotech buyer in Q2 2015 was Belmont Global Advisors, an estimated $1.22M added.
- The largest Fortress Biotech seller in Q2 2015 was RTW Investments, an estimated $1.67M sold.
Based on aggregated 13F filings for Q2 2015.